Johnson & Johnson (JNJ) Deferred Taxes (2009 - 2026)

Johnson & Johnson has disclosed Deferred Taxes across 18 years of filings, most recently posting $159.0 million for Q1 2026.

• Deferred Taxes for Q1 2026 came in at $159.0 million, down 92.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$475.0 million (down 130.63% YoY), and the FY2025 annual result was $1.5 billion, up 170.45% from the prior year.
• Deferred Taxes came in at $159.0 million for Q1 2026 at Johnson & Johnson, up from -$3.7 billion in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $2.2 billion in Q3 2025 to a low of -$3.7 billion in Q4 2025.
• The 5-year median for Deferred Taxes is -$16.0 million (2024), against an average of -$313.7 million.
• Peak annual rise in Deferred Taxes reached 2364.44% in 2025, while the deepest fall reached 22881.25% in 2025.
• Johnson & Johnson's Deferred Taxes stood at -$926.0 million in 2022, then sank by 160.48% to -$2.4 billion in 2023, then jumped by 99.34% to -$16.0 million in 2024, then slumped by 22881.25% to -$3.7 billion in 2025, then jumped by 104.32% to $159.0 million in 2026.
• The last three Deferred Taxes figures came in at $159.0 million (Q1 2026), -$3.7 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.